AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$15.72
+3.22% today
Updated 2026-05-11
Market cap
$2.02B
P/E ratio
7.28
P/S ratio
6.78x
EPS (TTM)
$2.16
Dividend yield
—
52W range
$7 – $17
Volume
1.2M
Aurinia Pharmaceuticals Inc (AUPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
100.00%
Operating margin
53.30%
ROE
65.00%
ROA
13.70%
Debt/equity
0.21x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.52M | $-22.85M | 83.05% | -685.66% | -648.73% |
| 2007 | $2.33M | $-33.82M | 55.02% | -1,543.04% | -1,448.70% |
| 2008 | $3.88M | $-15.88M | 45.44% | -422.00% | -409.67% |
| 2009 | $4.05M | $-7.60M | 85.79% | -247.91% | -187.51% |
| 2010 | $3.42M | $-3.66M | 98.51% | -147.53% | -107.02% |
| 2011 | $927522.00 | $-2.41M | 80.04% | -694.19% | -259.56% |
| 2012 | $6.16M | $-9.74M | 99.25% | -88.80% | -158.13% |
| 2013 | $948561.00 | $-2.55M | 99.90% | -580.40% | -268.42% |
| 2014 | $278000.00 | $-16.65M | 86.69% | -6,216.55% | -5,988.13% |
| 2015 | $235000.00 | $-18.61M | 94.89% | -10,034.04% | -7,917.87% |
| 2016 | $173000.00 | $-23.30M | 97.69% | -13,187.28% | -13,465.32% |
| 2017 | $420000.00 | $-70.79M | 99.76% | -11,205.48% | -16,855.24% |
| 2018 | $463000.00 | $-64.12M | -8,837.80% | -12,129.16% | -13,848.81% |
| 2019 | $318000.00 | $-88.39M | 100.00% | -28,598.43% | -27,794.03% |
| 2020 | $50.12M | $-102.68M | 100.00% | -208.09% | -204.88% |
| 2021 | $45.60M | $-180.97M | 97.61% | -396.31% | -396.81% |
| 2022 | $134.03M | $-108.18M | 95.77% | -83.17% | -80.71% |
| 2023 | $175.51M | $-78.02M | 91.94% | -52.24% | -44.45% |
| 2024 | $235.13M | $5.75M | 87.99% | -1.99% | 2.45% |
| 2025 | $283.06M | $287.20M | 88.46% | 37.06% | 101.47% |